文献速递艾滋病与性传播感染病毒性肝炎

肝纤维化与微生物移位对HIV和/或丙型肝炎病毒感染者免疫激活的贡献

Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
PubMed 文献 · J Infect Dis · 2018-01-01

在120例HIV/HCV共感染、262例HIV单感染、72例HCV单感染和170例未感染者中,评估肠脂肪酸结合蛋白(I-FABP)和瞬时弹性成像测定的肝纤维化是否介导HIV和HCV与可溶性CD14(sCD14)水平的关联。结果显示HIV和HCV独立且叠加地与较高sCD14水平相关;在HIV感染组I-FABP是主要介导因素,在HCV单感染组肝纤维化作用更强。

要点

  • HIV和HCV独立且叠加地与较高sCD14水平相关。
  • HIV感染中微生物移位指标I-FABP主要介导sCD14升高。
  • HCV单感染中肝纤维化对sCD14升高的介导作用更强。

核心结论

  • HIV和HCV独立且叠加地与较高sCD14水平相关。
  • 研究提示微生物移位在HIV感染中促进sCD14水平升高,而肝纤维化在HCV单感染中作用更强。
  • 共感染者可能因微生物移位和肝纤维化对免疫激活的独立效应而处于最高进展风险。

研究设计与样本

  • 采用多变量线性回归分析,评估I-FABP和瞬时弹性成像测定的肝纤维化是否介导HIV和HCV与sCD14水平的关联。
  • 研究纳入120例HIV/HCV共感染者、262例HIV单感染者、72例HCV单感染者和170例未感染者。

主要发现

  • 多变量调整后,共感染者、HIV单感染者和HCV单感染者的sCD14水平分别比未感染者高37%、21%和12%。
  • 进一步调整I-FABP水平后,HIV感染的关联适度减弱,但在HCV单感染组减弱程度较小。
  • 调整肝纤维化后,HCV感染的关联显著减弱,但在HIV单感染组减弱程度较小。
  • 相对于未感染组,HIV感染组中sCD14水平的主要介导因素是I-FABP水平,HCV单感染组中为肝纤维化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The independent contributions of microbial translocation and liver fibrosis to immune activation in human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV)-infected persons are unclear. METHODS: Multivariable linear regression was used to evaluate whether intestinal fatty acid binding protein (I-FABP: a marker of gut epithelial integrity) and transient elastography-measured liver fibrosis might mediate the association of HIV and HCV with the soluble CD14 (sCD14) level in 120 individuals with HIV and HCV coinfection, 262 with HIV monoinfection, 72 with HCV monoinfection, and 170 without infection. RESULTS: Coinfected individuals, HIV-monoinfected individuals, and HCV-monoinfected individuals had 37%, 21%, and 12% higher sCD14 levels, respectively, than uninfected individuals, after multivariable adjustment. Additional adjustment for I-FABP level modestly attenuated the association of HIV infection, but attenuation occurred to a lesser extent in the HCV-monoinfected group. Adjustment for liver fibrosis substantially attenuated the association of HCV infection, but attenuation occurred to a lesser extent in the HIV-monoinfected group. Relative to the uninfected group, the primary mediator of the sCD14 level was the I-FABP level in the HIV-infected groups and liver fibrosis in the HCV-monoinfected group. CONCLUSION: HIV and HCV are independently and additively associated with higher a sCD14 level. Our findings suggest that microbial translocation contributes to an increased sCD14 level during HIV infection, whereas liver fibrosis plays a stronger role during HCV monoinfection. Coinfected persons may be at greatest risk for progression, because of the independent effects of microbial translocation and liver fibrosis on immune activation.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Reid M, Ma Y, Scherzer R, et al. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus. J Infect Dis. 2018. PMID: 29304196. doi:10.1093/infdis/jix688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。